|
|
|||||||||||
The British Journal of Psychiatry 137: 522-529 (1980)
© 1980 The Royal College of Psychiatrists
JG Edwards, JR Alexander, MS Alexander, A Gordon and T Zutchi
In a double-blind comparative trial of sulpiride (600-1,800 mg/day) and trifluoperazine (15-45 mg/day) in 38 chronic schizophrenic patients, ratings of therapeutic results and unwanted effects were made at two- weekly interviews during the six weeks treatment period. The results show that sulpiride has neuroleptic properties and a spectrum of therapeutic activity similar to that of trifluoperazine. There was an association between plasma sulpiride levels and therapeutic response after four weeks' treatment.
This article has been cited by other articles:
![]() |
D. V. Jeste and R. Jed Wyatt Therapeutic Strategies Against Tardive Dyskinesia: Two Decades of Experience Arch Gen Psychiatry, July 1, 1982; 39(7): 803 - 816. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |